Loading...
Persistent Pricing Pressure And Commoditization Will Undermine Diabetes Care Outlook
AnalystLowTarget's Fair Value
US$11.00
35.8% overvalued intrinsic discount07 Aug
US$14.94
1Y
-54.6%7D
-2.9%1Y
-54.6%7D
-2.9%You can edit this narrative until Aug 7 10:17 PM. Then, changes will post as Updates.